Current Environment: Production

Beate Beinvogl | Education

Medical School

Technical University of Munich Medical School

Munich, Germany

Residency

Boston Combined Residency Program (BCRP)

2015, Boston, MA

Fellowship

Pediatric GI/Nutriton

Boston Children's Hospital

2018, Boston, MA

Beate Beinvogl | Certifications

  • American Board of Pediatrics (Gastroenterology)
  • American Board of Pediatrics (General)

Beate Beinvogl | Publications

  1. Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis. J Pediatr Gastroenterol Nutr. 2024 Sep; 79(3):501-509. View Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis. Abstract

  2. Impact of Coronavirus disease 2019 pandemic in children with functional abdominal pain disorders: Data from long-term follow-up. J Pediatr Gastroenterol Nutr. 2024 Jul; 79(1):26-34. View Impact of Coronavirus disease 2019 pandemic in children with functional abdominal pain disorders: Data from long-term follow-up. Abstract

  3. Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. J Pediatr. 2022 04; 243:14-20.e1. View Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. Abstract

  4. Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. J Pediatr Gastroenterol Nutr. 2021 12 01; 73(6):689-694. View Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. Abstract

  5. Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):513-519. View Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort. Abstract

  6. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):859-865. View Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. Abstract

  7. Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population. Neurogastroenterol Motil. 2021 11; 33(11):e14147. View Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population. Abstract

  8. Perceptions of Pain Treatment in Pediatric Patients With Functional Gastrointestinal Disorders. Clin J Pain. 2020 07; 36(7):550-557. View Perceptions of Pain Treatment in Pediatric Patients With Functional Gastrointestinal Disorders. Abstract

  9. Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate. Case Rep Pediatr. 2020; 2020:1929581. View Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate. Abstract

  10. Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses. J Pediatr. 2019 01; 204:162-171.e3. View Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses. Abstract

  11. Multidisciplinary Treatment Reduces Pain and Increases Function in Children With Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol. 2019 04; 17(5):994-996. View Multidisciplinary Treatment Reduces Pain and Increases Function in Children With Functional Gastrointestinal Disorders. Abstract

  12. Are We Using Abdominal Radiographs Appropriately in the Management of Pediatric Constipation? J Pediatr. 2017 12; 191:179-183. View Are We Using Abdominal Radiographs Appropriately in the Management of Pediatric Constipation? Abstract

  13. A 10-Month-Old With Intermittent Hypotonia and Paralysis. Pediatrics. 2016 07; 138(1). View A 10-Month-Old With Intermittent Hypotonia and Paralysis. Abstract

  14. MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. Leuk Res. 2012 Sep; 36(9):1185-92. View MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. Abstract

BESbswy